Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
2002.
Current Awareness.
International Journal of Geriatric Psychiatry,
Vol. 17,
Issue. 8,
p.
789.
Sweet, R A
Nimgaonkar, V L
Devlin, B
and
Jeste, D V
2003.
Psychotic symptoms in Alzheimer disease: evidence for a distinct phenotype.
Molecular Psychiatry,
Vol. 8,
Issue. 4,
p.
383.
Cook, Sarah E.
Miyahara, Sachiko
Bacanu, Silviu-Alin
Perez-Madriñan, Gina
Lopez, Oscar L.
Kaufer, Daniel I.
Nimgaonkar, Vishwajit L.
Wisniewski, Stephen R.
DeKosky, Steven T.
and
Sweet, Robert A.
2003.
Psychotic Symptoms in Alzheimer Disease: Evidence for Subtypes.
The American Journal of Geriatric Psychiatry,
Vol. 11,
Issue. 4,
p.
406.
2003.
The Neuropsychiatry of Alzheimer's Disease and Related Dementias.
p.
57.
Smith, Gwenn S
Lotrich, Francis E
Malhotra, Anil K
Lee, Annette T
Ma, Yilong
Kramer, Elisse
Gregersen, Peter K
Eidelberg, David
and
Pollock, Bruce G
2004.
Effects of Serotonin Transporter Promoter Polymorphisms on Serotonin Function.
Neuropsychopharmacology,
Vol. 29,
Issue. 12,
p.
2226.
Han, Doug Hyun
Park, Doo Byung
Na, Chul
Kee, Baik Seok
and
Lee, Young Sik
2004.
Association of aggressive behavior in Korean male schizophrenic patients with polymorphisms in the serotonin transporter promoter and catecholamine-O-methyltransferase genes.
Psychiatry Research,
Vol. 129,
Issue. 1,
p.
29.
Aarsland, Dag
and
Ballard, Clive
2004.
Psychiatric issues in non-Alzheimer dementias.
Clinical Neuroscience Research,
Vol. 3,
Issue. 6,
p.
397.
Craig, David
Hart, Dominic J.
Carson, Robin
McIlroy, Stephen P.
and
Passmore, A.Peter
2004.
Allelic variation at the A218C tryptophan hydroxylase polymorphism influences agitation and aggression in Alzheimer's disease.
Neuroscience Letters,
Vol. 363,
Issue. 3,
p.
199.
Förstl, H.
2005.
Das serotonerge System aus neurologischer und psychiatrischer Sicht.
p.
55.
Sweet, R A
Devlin, B
Pollock, B G
Sukonick, D L
Kastango, K B
Bacanu, S-A
Chowdari, K V
DeKosky, S T
and
Ferrell, R E
2005.
Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease.
Molecular Psychiatry,
Vol. 10,
Issue. 11,
p.
1026.
Borroni, B.
Grassi, M.
Agosti, C.
Costanzi, C.
Archetti, S.
Franzoni, S.
Caltagirone, C.
Di Luca, M.
Caimi, L.
and
Padovani, A.
2006.
Genetic correlates of behavioral endophenotypes in Alzheimer disease: Role of COMT, 5-HTTLPR and APOE polymorphisms.
Neurobiology of Aging,
Vol. 27,
Issue. 11,
p.
1595.
Cummings, Jeffrey L.
and
Zhong, Kate
2006.
Treatments for behavioural disorders in neurodegenerative diseases: drug development strategies.
Nature Reviews Drug Discovery,
Vol. 5,
Issue. 1,
p.
64.
Ballard, Clive
and
Howard, Robert
2006.
Neuroleptic drugs in dementia: benefits and harm.
Nature Reviews Neuroscience,
Vol. 7,
Issue. 6,
p.
492.
Wilkosz, Patricia A.
Miyahara, Sachiko
Lopez, Oscar L.
DeKosky, Steven T.
and
Sweet, Robert A.
2006.
Prediction of Psychosis Onset in Alzheimer Disease: The Role of Cognitive Impairment, Depressive Symptoms, and Further Evidence for Psychosis Subtypes.
The American Journal of Geriatric Psychiatry,
Vol. 14,
Issue. 4,
p.
352.
Forero, D. A.
Arboleda, G.
Yunis, J. J.
Pardo, R.
and
Arboleda, H.
2006.
Association study of polymorphisms in LRP1, tau and 5-HTT genes and Alzheimer’s disease in a sample of Colombian patients.
Journal of Neural Transmission,
Vol. 113,
Issue. 9,
p.
1253.
Meeks, Thomas W
Ropacki, Susan A
and
Jeste, Dilip V
2006.
The neurobiology of neuropsychiatric syndromes in dementia.
Current Opinion in Psychiatry,
Vol. 19,
Issue. 6,
p.
581.
Miczek, K. A.
Faccidomo, S. P.
Fish, E. W.
and
DeBold, J. F.
2007.
Handbook of Neurochemistry and Molecular Neurobiology.
p.
285.
Craig, David
Donnelly, Caroline
Hart, Dominic
Carson, Robyn
and
Passmore, Peter
2007.
Analysis of the 5HT‐2A T102C receptor polymorphism and psychotic symptoms in Alzheimer's disease.
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics,
Vol. 144B,
Issue. 1,
p.
126.
Pollock, Bruce G.
Mulsant, Benoit H.
Rosen, Jules
Mazumdar, Sati
Blakesley, Richard E.
Houck, Patricia R.
and
Huber, Kimberly A.
2007.
A Double-Blind Comparison of Citalopram and Risperidone for the Treatment of Behavioral and Psychotic Symptoms Associated With Dementia.
The American Journal of Geriatric Psychiatry,
Vol. 15,
Issue. 11,
p.
942.
Sweet, Robert A.
and
Emanuel, James E.
2007.
The Spectrum of Psychotic Disorders.
p.
455.